Paper39697248
Microwave-assisted synthesis of base-modified fluorescent 1,4-dihydropyridine nucleosides: photophysical characterization and insights.
Arora A and 3 others. RSC Adv, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Microwave-assisted synthesis of base-modified fluorescent 1,4-dihydropyridine nucleosides: photophysical characterization and insights. Papers, record 39697248. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39697248
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Microwave-assisted synthesis of base-modified fluorescent 1,4-dihydropyridine nucleosides: photophysical characterization and insights.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11052795 | Synthesis and antiviral activity of oxaselenolane nucleosides. | J Med Chem | 2000 | https://conductscience.org/library/papers/11052795 | PubMed |
| 2 | 16214352 | Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: novel compounds against aspergillosis. | Bioorg Med Chem | 2006 | https://conductscience.org/library/papers/16214352 | PubMed |
| 3 | 23722347 | Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. | Nat Rev Drug Discov | 2013 | https://conductscience.org/library/papers/23722347 | PubMed |
| 4 | 16603351 | A pyrimidine-pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity. | Bioorg Med Chem Lett | 2006 | https://conductscience.org/library/papers/16603351 | PubMed |
| 5 | 9342503 | Clinical pharmacokinetics of stavudine. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9342503 | PubMed |
| 6 | 23364618 | Synthesis and spectroscopic properties of fluorescent 5-benzimidazolyl-2'-deoxyuridines 5-fdU probes obtained from o-phenylenediamine derivatives. | Org Biomol Chem | 2013 | https://conductscience.org/library/papers/23364618 | PubMed |
| 7 | 18431439 | Furan Decorated Nucleoside Analogues as Fluorescent Probes: synthesis, photophysical evaluation and site-specific incorporation. | Tetrahedron | 2007 | https://conductscience.org/library/papers/18431439 | PubMed |
| 8 | 17576372 | Solvent effects on the steady-state absorption and fluorescence spectra of uracil, thymine and 5-fluorouracil. | Photochem Photobiol | 2007 | https://conductscience.org/library/papers/17576372 | PubMed |
| 9 | 38808609 | Synthesis, characterization and photophysical studies of dual-emissive base-modified fluorescent nucleosides. | Org Biomol Chem | 2024 | https://conductscience.org/library/papers/38808609 | PubMed |
| 10 | 21382653 | Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines. | Eur J Med Chem | 2011 | https://conductscience.org/library/papers/21382653 | PubMed |
| 11 | 25881643 | 2-Aminopurine as a fluorescent probe of DNA conformation and the DNA-enzyme interface. | Q Rev Biophys | 2015 | https://conductscience.org/library/papers/25881643 | PubMed |
| 12 | 29474268 | Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection. | J Acquir Immune Defic Syndr | 2018 | https://conductscience.org/library/papers/29474268 | PubMed |
| 13 | 16996561 | The Ugi reaction in the generation of new nucleosides as potential antiviral and antileishmanial agents. | Bioorg Chem | 2007 | https://conductscience.org/library/papers/16996561 | PubMed |
| 14 | 10595868 | Stavudine: an update of its use in the treatment of HIV infection. | Drugs | 1999 | https://conductscience.org/library/papers/10595868 | PubMed |
| 15 | 32354007 | Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues. | Molecules | 2020 | https://conductscience.org/library/papers/32354007 | PubMed |
| 16 | 2879972 | Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine. | Lancet | 1987 | https://conductscience.org/library/papers/2879972 | PubMed |
| 17 | 22100257 | Efficient microwave-assisted synthesis, antibacterial activity and high fluorescence of 5 benzimidazolyl-2'-deoxyuridines. | Bioorg Med Chem | 2012 | https://conductscience.org/library/papers/22100257 | PubMed |
| 18 | 21968373 | Hantzsch reaction: synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents. | Eur J Med Chem | 2011 | https://conductscience.org/library/papers/21968373 | PubMed |
| 19 | 35694298 | 1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35694298 | PubMed |
| 20 | 10439933 | Lamivudine. A review of its therapeutic potential in chronic hepatitis B. | Drugs | 1999 | https://conductscience.org/library/papers/10439933 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39697248
GET https://conductscience.org/api/papers/v1/39697248/references?page=2